Zdrowie i gospodarka · 23/08/2017
FDA Releases Draft Guidance on Identifying Trading Partners Under the Drug Supply Chain Security Act
The US Food and Drug Administration (FDA) has published a draft guidance for industry on identifying trading partners under the Drug Supply Chain Security Act, with the document now available for public comment